Carbetapentane and guaifenesin and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Carbetapentane and guaifenesin and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbetapentane / guaifenesin
Brand name: Allfen C, Allfen CX, Xpect-AT, BetaVent, Oratuss, Pulmari-GP, Certuss, Dynex VR, Carba-XP, AMBI 1000/5, Duratuss CS, Respi-Tann G, Allres-G, Tusso-ZR, Tusso-ZMR, exall, Expectuss
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbetapentane and guaifenesin-Insulin degludec
- Carbetapentane and guaifenesin-Insulin Degludec (U-100) Prefilled Pens
- Carbetapentane and guaifenesin-Insulin Degludec (U-100) Vials
- Carbetapentane and guaifenesin-Insulin Degludec (U-200) Prefilled Pens
- Carbetapentane and guaifenesin-Insulin degludec and liraglutide
- Carbetapentane and guaifenesin-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Carbetapentane and pseudoephedrine
- Insulin aspart, recombinant Subcutaneous-Carbidopa
- Insulin aspart, recombinant Subcutaneous-Carbidopa and levodopa
- Insulin aspart, recombinant Subcutaneous-Carbidopa and levodopa enteral
- Insulin aspart, recombinant Subcutaneous-Carbidopa and Levodopa Enteral Suspension
- Insulin aspart, recombinant Subcutaneous-Carbidopa and Levodopa Extended-Release Capsules